Can non-invasive assessment of liver fibrosis replace liver biopsy?

Hepatology Research

Volumn 42, Issue 3, 2012, Pages 233-240

  Yoshioka, Kentaro ^a   Hashimoto, Senju ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Acoustic radiation force impulse; Fibrosis stage; Inflammatory activity; Liver stiffness; Real time elastography; Transient elastography

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; HYALURONIC ACID; INTERLEUKIN 28B; IRON; PEGINTERFERON; PEGINTERFERON ALPHA2B; PROTHROMBIN; RIBAVIRIN;

ACOUSTIC RADIATION FORCE IMPULSE IMAGING; ANTIVIRAL THERAPY; BODY MASS; DISEASE COURSE; ELASTOGRAPHY; GENE MUTATION; HEPATITIS B; HEPATITIS C; HIGH RISK PATIENT; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; NON INVASIVE PROCEDURE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REAL TIME ELASTOGRAPHY; REMISSION; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE COUNT; TRANSIENT ELASTOGRAPHY; TREATMENT RESPONSE; VIRUS GENOME;

EID: 84857563277     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00928.x     Document Type: Review

References (50)

1. Forns X, Ampurdanes S, Llovet JM etal. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36: 986-92.
2. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-75.
3. Murawaki Y, Ikuta Y, Okamoto K, Koda M, Kawasaki H. Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C. J Gastroenterol 2001; 36: 399-406.
4. Poynard T, Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J Viral Hepat 1997; 4: 199-208.
5. Rosenberg WM, Voelker M, Thiel R etal. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004; 127: 1704-13.
6. Wai CT, Greenson JK, Fontana RJ etal. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-26.
7. Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 2007; 45: 297-306.
8. Sandrin L, Fourquet B, Hasquenoph JM etal. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-13.
9. Nitta Y, Kawabe N, Hashimoto S etal. Liver stiffness measured by transient elastography correlates with fibrosis area in liver biopsy in patients with chronic hepatitis C. Hepatol Res 2009; 39: 675-84.
10. Friedrich-Rust M, Wunder K, Kriener S etal. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 2009; 252: 595-604.
11. Friedrich-Rust M, Ong MF, Herrmann E etal. Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis. AJR Am J Roentgenol 2007; 188: 758-64.
12. Yin M, Talwalkar JA, Glaser KJ etal. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007; 5: 1207-13. e2.
13. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-57.
14. Regev A, Berho M, Jeffers LJ etal. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-18.
15. Kumada H, Okanoue T, Onji M etal. Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan. Hepatol Res 2010; 40: 8-13.
16. Kumada H, Okanoue T, Onji M etal. Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan. Hepatol Res 2010; 40: 1-7.
17. Friedrich-Rust M, Ong MF, Martens S etal. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960-74.
18. Yoshioka K, Kawabe N, Hashimoto S. Transient elastography: applications and limitations. Hepatol Res 2008; 38: 1063-8.
19. Friedrich-Rust M, Schwarz A, Ong M etal. Real-time tissue elastography versus FibroScan for noninvasive assessment of liver fibrosis in chronic liver disease. Ultraschall Med 2009; 30: 478-84.
20. Koizumi Y, Hirooka M, Kisaka Y etal. Liver fibrosis in patients with chronic hepatitis C: noninvasive diagnosis by means of real-time tissue elastography - establishment of the method for measurement. Radiology 2011; 258: 610-17.
21. Takahashi H, Ono N, Eguchi Y etal. Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study. Liver Int 2009; 30: 538-45.
22. Fierbinteanu-Braticevici C, Andronescu D, Usvat R, Cretoiu D, Baicus C, Marinoschi G. Acoustic radiation force imaging sonoelastography for noninvasive staging of liver fibrosis. World J Gastroenterol 2009; 15: 5525-32.
23. Lupsor M, Badea R, Stefanescu H etal. Performance of a new elastographic method (ARFI technology) compared to unidimensional transient elastography in the noninvasive assessment of chronic hepatitis C. Preliminary results. J Gastrointestin Liver Dis 2009; 18: 303-10.
24. Sporea I, Sirli R, Popescu A, Danila M. Acoustic Radiation Force Impulse (ARFI) - a new modality for the evaluation of liver fibrosis. Med Ultrasound 2010; 12: 26-31.
25. Toshima T, Shirabe K, Takeishi K etal. New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver. J Gastroenterol 2011; 46: 705-11.
26. Ebinuma H, Saito H, Komuta M etal. Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with Fibroscan((R)). J Gastroenterol 2011; 46: 1238-48.
27. Sporea I, Sirli RL, Deleanu A etal. Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies. Ultraschall Med 2011; 32 (Suppl 1): S46-52.
28. Grgurevic I, Cikara I, Horvat J etal. Noninvasive assessment of liver fibrosis with acoustic radiation force impulse imaging: increased liver and splenic stiffness in patients with liver fibrosis and cirrhosis. Ultraschall Med 2011; 32: 160-6.
29. Piscaglia F, Salvatore V, Di Donato R etal. Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography. Ultraschall Med 2011; 32: 167-75.
30. Ichino N, Osakabe K, Nishikawa T etal. A new index for non-invasive assessment of liver fibrosis. World J Gastroenterol 2010; 16: 4809-16.
31. Boursier J, Vergniol J, Sawadogo A etal. The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis. Liver Int 2009; 29: 1507-15.
32. Hayashi K, Katano Y, Honda T etal. Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy. Liver Int 2011 31: 1359-65.
33. Poynard T, Munteanu M, Colombo M etal. FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC(3) program. J Hepatol 2011; 54: 227-35.
34. Ogawa E, Furusyo N, Toyoda K, Takeoka H, Maeda S, Hayashi J. The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin. Antiviral Res 2009; 83: 127-34.
35. Arima Y, Kawabe N, Hashimoto S etal. Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C. Hepatol Res 2010; 40: 383-92.
36. Wang JH, Changchien CS, Hung CH etal. Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: longitudinal study using FibroScan. J Gastroenterol Hepatol 2010; 25: 964-9.
37. Osakabe K, Ichino N, Nishikawa T etal. Reduction of liver stiffness by antiviral therapy in chronic hepatitis B. J Gastroenterol 2011; (in press).
38. Enomoto M, Mori M, Ogawa T etal. Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: regression of liver stiffness during entecavir therapy. Hepatol Res 2010; 40: 853-61.
39. Ikeda K, Saitoh S, Suzuki Y etal. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 1998; 28: 930-8.
40. Zaman A, Hapke R, Flora K, Rosen HR, Benner K. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol 1999; 94: 3292-6.
41. Stefanescu H, Grigorescu M, Lupsor M etal. A new and simple algorithm for the noninvasive assessment of esophageal varices in cirrhotic patients using serum fibrosis markers and transient elastography. J Gastrointestin Liver Dis 2011; 20: 57-64.
42. Lok AS, Ghany MG, Goodman ZD etal. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 2005; 42: 282-92.
43. Jung KS, Kim SU, Ahn SH etal. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 2011; 53: 885-94.
44. Masuzaki R, Tateishi R, Yoshida H etal. Risk assessment of hepatocellular carcinoma in chronic hepatitis C patients by transient elastography. J Clin Gastroenterol 2008; 42: 839-43.
45. Masuzaki R, Tateishi R, Yoshida H etal. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 2009; 49: 1954-61.
46. Harata M, Hashimoto S, Kawabe N etal. Liver stiffness in extrahepatic cholestasis correlates positively with bilirubin and negatively with alanine aminotransferase. Hepatol Res 2011; 41: 423-9.
47. Poynard T, Munteanu M, Ngo Y etal. ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure. Gastroenterol Clin Biol 2010; 34: 388-96.
48. Hatta T, Fujinaga Y, Kadoya M etal. Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease. J Gastroenterol 2010; 45: 1263-71.
49. Poynard T, Ratziu V, Naveau S etal. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol 2005; 4: 10.
50. Sirlin CB, Reeder SB. Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am 2010; 18: 359-81. ix.